CAS NO: | 285986-88-1 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
1 g | 电议 |
生物活性 |
CCG-1423 is an inhibitor ofRho/MRTF/SRFpathway. CCG-1423 shows activities in severalcancercells. CCG-1423 is a promising lead compound for the development of novel pharmacologic tools, and it can be used for the research ofcancerand diabetes[1][2][3]. |
||||||||||||||||||||||||||||||||
IC50& Target |
IC50: 1.5 μM (Rho-pathway selective serum response element-luciferase reporter)[1] |
||||||||||||||||||||||||||||||||
体外研究 (In Vitro) |
CCG-1423 (10 μM; 24 h) affects invasion by cultured PC-3 cells into a Matrigel matrix and inhibits 54% mitochondrial metabolism of WST-1[1].
Cell Invasion Assay[1]
Western Blot Analysis[2]
Cell Proliferation Assay[3]
Apoptosis Analysis[3]
|
||||||||||||||||||||||||||||||||
体内研究 (In Vivo) |
CCG-1423 (0.15 mg/kg; i.p. once daily for two weeks) affects glucose tolerance and insulin levels in HFD-fed mice[1].
|
||||||||||||||||||||||||||||||||
分子量 |
454.75 |
||||||||||||||||||||||||||||||||
性状 |
Solid |
||||||||||||||||||||||||||||||||
Formula |
C18H13ClF6N2O3 |
||||||||||||||||||||||||||||||||
CAS 号 |
285986-88-1 |
||||||||||||||||||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||||||||||||||||||
储存方式 |
|
||||||||||||||||||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL(219.90 mM;ultrasonic and warming and heat to 60℃)
配制储备液
*
请根据半岛bd体育手机客户端 在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的半岛bd体育手机客户端 失效。
In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
*
以上所有助溶剂都可在本网站选购。
|